论文部分内容阅读
目的:分析探讨在儿童咳嗽变异性哮喘治疗中,普米克令舒的治疗疗效。方法:选取本院收治的咳嗽变异性哮喘患儿73例为研究对象,采用数字随机法将所有患儿随机分为对照组与实验组,对照组38例行常规西药治疗,实验组35例行普米克令舒+常规西药治疗,比较两组患儿治疗后的治疗效果与不良反应。结果:实验组患儿治疗总有效率为97.1%,显著高于对照组76.3%(P<0.01),而显效率为85.7%,显著高于对照组50.0%(P<0.01)。结论:在儿童咳嗽变异性哮喘治疗中,普米克令舒的治疗疗效更加显著,无不良反应,因此具有临床推广与应用的价值。
Objective: To analyze the therapeutic effect of Pulmicort respules in the treatment of children with cough variant asthma. Methods: A total of 73 children with cough variant asthma admitted to our hospital were enrolled in this study. All children were randomly divided into control group and experimental group by digital random method. In the control group, 38 cases were treated with conventional western medicine and 35 cases in experimental group Pulmicort respules + conventional western medicine, the treatment effect and adverse reactions of the two groups were compared. Results: The total effective rate of treatment group was 97.1%, significantly higher than that of control group 76.3% (P <0.01), while the markedly effective rate was 85.7%, which was significantly higher than that of control group 50.0% (P <0.01). Conclusions: Pulmicort respiratiation is more effective in children with cough variant asthma and has no adverse reactions, so it has the value of clinical popularization and application.